Episode 47
Biotech Hangout
00:00
The FDA Approval for Chronic Kidney Disease (CKD)
It's approved only for anemia in the context of end-stage renal disease and patients on dialysis. Now, a lot of those patients can just get hypo infusions at the time of their dialysis. It'll be interesting to see if that's something that you just try to do more in the name of profit rather than patient interest. So it'll be something to keep an eye on and to watch, but it was an interesting panel.
Play episode from 35:46
Transcript
